Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Common Equity (2020 - 2026)

Alvotech's (ALVO) quarterly Common Equity came in at -$191.5 million in Q2 2026, down 10.47% on a YoY basis from -$213.9 million in Q2 2025, and up 32.17% quarter-over-quarter from -$282.3 million in Q1 2026.

Analysis

Alvotech (ALVO) Common Equity (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Common Equity for 7 consecutive years, with -$191.5 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Common Equity fell 10.47% year-over-year to -$191.5 million; the trailing twelve-month figure through Jun 2026 stood at -$191.5 million (down 10.47% YoY), and the FY2025 full-year result was -$284.5 million, up 31.08% from the prior year.
  • Common Equity rose to -$191.5 million in Q2 2026 per ALVO's latest filing, from -$282.3 million in the prior quarter.
  • Across five years, Common Equity topped out at -$173.3 million in Q2 2025 and bottomed at -$932.5 million in Q4 2023.
  • Historically, Common Equity has averaged -$432.1 million across 5 years, with a median of -$412.8 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Common Equity plunged 316.2% in 2022, then soared 71.39% in 2025.
  • Over 5 years, Common Equity stood at -$564.4 million in 2022, then sank by 65.21% to -$932.5 million in 2023, then soared by 55.73% to -$412.8 million in 2024, then surged by 31.08% to -$284.5 million in 2025, then soared by 32.69% to -$191.5 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered -$191.5 million, -$282.3 million, and -$284.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 7.76 Bn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn 14.26 Bn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 4.08 Bn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 33.02 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn -1.77 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -191.48 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 597.21 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 768.16 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 42.44 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - 4.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -191.48 Mn
Mar 31, 2026 -282.31 Mn
Dec 31, 2025 -284.49 Mn
Sep 30, 2025 -412.77 Mn
Jun 30, 2025 -173.33 Mn
Mar 31, 2025 -412.77 Mn
Dec 31, 2024 -412.77 Mn
Sep 30, 2024 -343.71 Mn
Jun 30, 2024 -605.92 Mn
Mar 31, 2024 -658.83 Mn
Dec 31, 2023 -932.49 Mn
Jun 30, 2023 -478.54 Mn
Dec 31, 2022 -564.42 Mn
Jun 30, 2022 -296.22 Mn
Dec 31, 2021 -135.61 Mn
Dec 31, 2020 -867.24 Mn